Skip to content

Positive Suggestions Via MP3 Messages

Delivering Positive Suggestions to the Critically Ill Patients Via Pre-recorded MP3 Messages to Improve Mental Health Outcomes

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04437095
Enrollment
149
Registered
2020-06-18
Start date
2020-08-17
Completion date
2025-02-07
Last updated
2025-03-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety, Depression, Post Intensive Care Unit Syndrome, Psychological Trauma, PTSD

Keywords

Post traumatic stress syndrome, Anxiety, Depression, PICS

Brief summary

The purpose of this study is to assess the use of an audio recording containing positive suggestion as a means to provide needed psychological support to critically ill patients in a feasible and reliable manner.

Detailed description

Following screening and consenting processes, patients will be randomized to enroll in interventional or control groups. The interventional group will listen to an audio recording of psychological support based on positive suggestion for about 30 min each day via headphones. At the time of ICU discharge, patients will be administered validated questionnaires to screen for symptoms of anxiety/depression (HADS), PTSD (IES-r), cognitive dysfunction (MOCA-blind), as well as evaluation of health status (EQ-5D). Six months post ICU discharge, patients will again be contacted and repeat the assessment with above questionnaires. Scores on the questionnaires will be compared between the groups at the two times points. Patient demographic data will also be obtained and assessed to contextualize study findings.

Interventions

OTHERPsychological Support Based on Positive Suggestion delivered via pre-recorded MP3 message

Daily administration of audiorecording

Sponsors

Mayo Clinic
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Intervention model description

Patients will be randomized 1:1 to intervention vs standard care. Using data from our prior observational study, mean (SD) HADS-Anxiety subscale was 7.3 (4.1) among these subjects (coefficient of variation = 4.1/7.3 = 0.56). A total 300 subjects will be enrolled and randomized until 100 subjects per arm recruitment target is reached to allow for mortality and dropout. The analysis will compare 6 month HADS-A by treatment arms using ANCOVA. The analysis will be conducted under a modified intention to treat principle, with subjects analyzed according to randomized arm, but excluding patients who die before follow up. Additional outcomes including HADS-D, MoCA-blind, and EQ-5D will be analyzed similarly using ANCOVA, and IES-R subscore\>1.6 will be analyzed by Chi-square test.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Acute respiratory failure and/or requiring vasopressors * Admitted to the ICU * Expected to stay \>48 hours in the ICU

Exclusion criteria

* History of dementia * History of mental retardation * History of suicide attempt * History of psychotic disorders such as schizophrenia * Acute alcohol/substance intoxication or withdrawal * Severe metabolic encephalopathy * Patients on comfort care * Patients not expected to survive the hospital stay * Those with hearing impairment * Non-English speaking.

Design outcomes

Primary

MeasureTime frameDescription
Hospital Anxiety and Depression Scale (HADS) - Anxietywithin 96 hours of ICU dischargeA self-reported questionnaire designed to identify anxiety and depression. Each item is rated on a 4-point scale from 0 absence to 3 extreme presence. Total score is 21 per subscale: 0 - 7: Normal levels of anxiety/depression; 8-10: Borderline abnormal; \> 11: Abnormal. Total questions: 14 Anxiety 7 Depression 7 A self-reported questionnaire designed to identify anxiety and depression. Each item is rated on a 4-point scale from 0 absence to 3 extreme presence. Total score is 21. Per subscale: 0 - 7: Normal levels of anxiety/depression; 8-10: Borderline abnormal; \> 11: Abnormal. TL questions: 14: Anxiety 7, Depression 7

Secondary

MeasureTime frameDescription
Montreal Cognitive Assessment-Blind (MoCA-blind)within 96 hours of ICU dischargeA screening tool designed to detect mild cognitive dysfunction. Subscores for each of the 5 sections are calculated. The total score is summed from the subscores, with a maximum score of 22. A score equal \> 18 is considered normal cognition. Total questions:13: Memory 3, Attention 4, Language 3, Abstraction 2, Orientation 1
EQ-5Dwithin 96 hours of ICU dischargeA self-report questionnaire of health status or health-related quality of life. Scoring information: 5L - 5 levels of severity: no problems, slight problems, moderate problems, severe problems, extreme problems. The visual analog scale ranges from 0 to 100 with higher scores reflecting better perceived current health-related quality of life state. Total questions: 6 Mobility: 1 Self-Care: 1 Usual Activities: 1 Pain/discomfort: 1 Anxiety/depression: 1 Health State - Visual Analog Scale: 1
Impact of Events Scale-Revisedwithin 96 hours of ICU dischargeA self-reported questionnaire designed to measure distress caused by traumatic events. Items are rated on a 5-point scale ranging from 0 (not at all) to 4 (extremely). Total scores are summed with higher scores indicating greater distress with regards to a specific event. Total questions: 22: Intrusion 7, Avoidance 8, Hyperarousal 7
Hospital Anxiety and Depression Scale (HADS) - Depressionwithin 96 hours of ICU dischargeA self-reported questionnaire designed to identify anxiety and depression. Each item is rated on a 4-point scale from 0 absence to 3 extreme presence. Total score is 21. Per subscale: 0 - 7: Normal levels of anxiety/depression; 8-10: Borderline abnormal; \> 11: Abnormal. Total questions: 14: Anxiety 7, Depression 7
Hospital Anxiety and Depression Scale (HADS) - Anxiety6 months following ICU dischargeA self-reported questionnaire designed to identify anxiety and depression. Each item is rated on a 4-point scale from 0 absence to 3 extreme presence. Total score is 21. Per subscale: 0 - 7: Normal levels of anxiety/depression; 8-10: Borderline abnormal; \> 11: Abnormal. Total questions: 14: Anxiety 7, Depression 7

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026